Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

1998 • 4,297 citations

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 • 2,670 citations

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1998 • 2,421 citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 • 1,912 citations

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

1996 • 1,045 citations

Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

1999 • 850 citations

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine

1996 • 758 citations

A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease

1995 • 569 citations

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease

1998 • 553 citations

Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals

1996 • 510 citations

A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection

1995 • 484 citations

Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community

1994 • 372 citations

Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.

1996 • 342 citations

Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease

1995 • 297 citations

Antituberculosis Drug–induced Hepatotoxicity

1998 • 285 citations

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors

1998 • 265 citations

The Influence of Human Immunodeficiency Virus Type 1 Infection on the Development of the Hepatitis B Virus Carrier State

1991 • 264 citations

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

1997 • 248 citations

Impact of Treatment with Human Immunodeficiency Virus (HIV) Protease Inhibitors on Hepatitis C Viremia in Patients Coinfected with HIV

1998 • 195 citations

A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)‐1 Protease, to Treat HIV Infection

1998 • 148 citations

Protease Inhibitors in the Homeless

1997 • 144 citations

Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections

1996 • 132 citations

Chronic Hepatitis B in Asymptomatic Homosexual Men with Antibody to the Human Immunodeficiency Virus

1986 • 117 citations

Tritherapy for Human Immunodeficiency Virus Infection Does Not Modify Replication of Hepatitis C Virus in Coinfected Subjects

1998 • 95 citations

Interactions and Toxicities of Drugs Used in Patients with AIDS

1992 • 72 citations

Adverse Events from Drug Therapy for Human Immunodeficiency Virus Disease

1996 • 71 citations

Value of Epidemiologic Studies in Determining the True Incidence of Adverse Events

1997 • 38 citations